GL1X · GenesisL1 explorer

MolNFT v1 · #182213 · protein

Augmentor domain of augmentor-beta

7MK7 · ALK and ltk ligand 1,MALTODEXTRIN-binding protein: “Augmentor domain of augmentor-beta”. X-ray diffraction, 1 ligand (GLC), 2 pockets (best druggability 0.70). MolNFT v1 #182213 on GenesisL1: 3D structure, binding sites and pockets…

PDB
7MK7
Type
protein
Length
737 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK and ltk ligand 1,MALTODEXTRIN-binding protein
UniProt
Q6UXT8, A0A2Y0TBT9
Ligands
GLC
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 47% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK and ltk ligand 1,MALTODEXTRIN-binding proteinprotein36946% helix, 17% strandQ6UXT8, A0A2Y0TBT9
BALK and ltk ligand 1,MALTODEXTRIN-binding proteinprotein36848% helix, 18% strandQ6UXT8, A0A2Y0TBT9

Ligands and binding sites

  • GLC · alpha-D-glucopyranose · sugar · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12970.700.8426GLC
22630.670.8326GLC

Interfaces

1 interface between chains.

  • A–B · 809 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 7MK7 · Augmentor domain of augmentor-beta · the same entry in another collection · chain A against A, TM-score 1.00
  • Q6UXT8 · AlphaFold monomer V2.0 prediction for ALK and ltk ligand 1 (Q6UXT8) · a predicted model of the same protein · chain A against A, TM-score 0.13

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.